You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (7) |
Back to Search
Uptake mechanism of erythromycin at the blood-placenta barrier
- In: SIG: Individualised Medicine - Posters
- At: Basel (Switzerland) (2008)
- Type: Poster
- Poster code: IM-P-001
- By: SAI, Yoshimichi (Keio University Faculty of Pharmacy, Tokyo, Japan)
- Co-author(s): Takagi, Akinori (Keio University Faculty of Pharmacy, TOKYO, Japan)
Ochi, Kaori (Keio University Faculty of Pharmacy, TOKYO, Japan)
Kose, Noriko (Keio University Faculty of Pharmacy, TOKYO, Japan)
Nishimura, Tomohiro (Keio University Faculty of Pharmacy, TOKYO, Japan)
Nakashima, Emi (Keio University Faculty of Pharmacy, TOKYO, Japan) - Abstract:
Infectious diseases in pregnancy increase a risk of serious disorder of fetus including early delivery, abortion and prenatal growth delay. Therefore, antibiotics are used to pregnant women in case benefits outweigh risks. Erythromycin (EM) is a macrolide antibiotics used for chlamydial, syphilis and mycoplasma infections. Although transplacental..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026